Multiple Sclerosis: Subtypes, Symptoms, Diagnosis & Treatment Document List

Publication List:

Stem cell treatment improves established disability in patients with progressive MS and shows there is hope future treatment is possible - Published: 2016-04-15

Summary of significant 2015 multiple sclerosis research progress and initiatives from The National Multiple Sclerosis Society - Published: 2015-12-29

New research could lead to the development of new types of drugs to treat Multiple Sclerosis (MS) - Published: 2015-02-18

Follow-up of girls and women who received human papillomavirus (HPV) vaccination found no increased risk for these disorders - Published: 2015-01-11

Research scientists are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patients own cells - Published: 2014-07-24

Case discovered that her inability to walk and other MS symptoms were triggered by her dental mercury fillings - Published: 2013-01-03

Health Canada approved FAMPYRA on February 10, 2012 for the symptomatic improvement of walking in adult MS patients with walking disability - Published: 2012-04-12

Minimally invasive endovascular treatment for CCSVI may produce significant improvement in physical and mental quality of life in individuals with MS - Published: 2012-03-27

Diagnostic breakthrough in multiple sclerosis reveals cause may be bio-mechanical related to earlier trauma to the neck resulting in obstruction of cerebrospinal fluid flow - Published: 2011-10-06

Molecular mechanism could bring about the development of new treatments for Multiple Sclerosis (MS) - Published: 2011-06-30

Endovascular therapy or angioplasty is the nonsurgical procedure of threading a thin tube into a vein or artery to open blocked or narrowed blood vessels - Published: 2011-06-23

There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence - Published: 2011-06-12

Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease - Published: 2011-05-19

New class of highly selective compounds that effectively suppresses the severity of multiple sclerosis - Published: 2011-04-18

Predicting whether patients will suffer a faster onset of disability and counsel them to help ease anxiety - Published: 2011-04-15

Gilenya delayed progression of disability both for patients who were previously treated for their MS and for patients who had not received prior treatment - Published: 2011-04-11

Multiple sclerosis is a seriously disabling autoimmune disease that can lead to disturbance or loss of sensory function voluntary movement vision and bladder control - Published: 2011-03-31

People living with MS need more information to make the best choices for the benefit of their health - Published: 2011-03-30

Multiple sclerosis is a life altering disease that affects each person in a unique and different way - Published: 2011-03-14

Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS) - Published: 2011-03-10

Fumaric acid salts used against severe psoriasis may also have a favorable effect on Multiple Sclerosis as a result of their TH2 polarizing mechanisms - Published: 2011-03-07

Damage to a particular area of the brain and a consequent reduction in noradrenaline are associated with multiple sclerosis - Published: 2011-02-13

Histamine could be an important molecule to developing new treatments for multiple sclerosis (MS) - Published: 2011-01-31

MS Progress was made toward finding ways to restore function and improving quality of life through exercise meditation rehabilitation and medications - Published: 2010-12-20

Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system - Published: 2010-12-05

The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine - Published: 2010-10-28

Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients - Published: 2010-10-17

Albuterol sulfate used to treat bronchospasm in asthma may decrease interleukin-12 levels - Published: 2010-09-13

Meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada - Published: 2010-09-01

Trial to test bone marrow stem cell therapy with patients with multiple sclerosis shown to have possible benefits for treatment of the disease - Published: 2010-08-28

Society of Interventional Radiology would like to be actively involved in developing evidence-based therapies for the potential treatment of patients with multiple sclerosis - Published: 2010-08-26

Hard To Treat Diseases (HTDS.PK) Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment - Published: 2010-06-03

Join the Movement to End Multiple Sclerosis During MS Awareness Week March 8-14, 2010 - Published: 2010-03-08

FDA approves Ampyra (dalfampridine) drug to improve walking in patients with multiple sclerosis (MS) - Published: 2010-01-24

Major trial of oral drug Cladribine has shown it significantly reduces relapse and deterioration of multiple sclerosis (MS) - Published: 2010-01-20

National Multiple Sclerosis Society continues to propel research forward to end MS - Published: 2009-12-23

People with multiple sclerosis who have relapses within five years of onset have more severe disability in the short term - Published: 2009-11-05

Research study could overturn the prevailing wisdom on the cause of multiple sclerosis (MS) - Published: 2009-10-25

Study finds two genes associated with good central nervous system repair in multiple sclerosis - Published: 2009-09-11

Virus responsible for rare brain disease found to be reactivated in multiple-sclerosis patients being treated with natalizumab - Published: 2009-09-10

A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder - Published: 2009-08-11

Antegren for multiple sclerosis is a monoclonal antibody that is given by monthly infusion into a vein - Published: 2009-02-27

The drug Naltrexone has stopped the progression of Multiple Sclerosis and enhanced the quality of life for Multiple Sclerosis sufferers - Published: 2009-02-27

Experimental drug fampridine 4-aminopyridine improves walking ability in some individuals with multiple sclerosis MS - Published: 2009-02-27